245 related articles for article (PubMed ID: 25615415)
21. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
[TBL] [Abstract][Full Text] [Related]
22. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL.
Huang S; Qiu Y; Shi Y; Xu Z; Brandt SJ
EMBO J; 2000 Dec; 19(24):6792-803. PubMed ID: 11118214
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation by TAL1: a link between epigenetic modifications and erythropoiesis.
Hu X; Ybarra R; Qiu Y; Bungert J; Huang S
Epigenetics; 2009 Aug; 4(6):357-61. PubMed ID: 19736520
[TBL] [Abstract][Full Text] [Related]
24. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
Cho HS; Kim MK; Bae YK
Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
[TBL] [Abstract][Full Text] [Related]
25. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
26. Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.
Zhou Y; Kurukuti S; Saffrey P; Vukovic M; Michie AM; Strogantsev R; West AG; Vetrie D
Blood; 2013 Dec; 122(26):4199-209. PubMed ID: 24200685
[TBL] [Abstract][Full Text] [Related]
27. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
28. Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia.
Correia NC; Durinck K; Leite AP; Ongenaert M; Rondou P; Speleman F; Enguita FJ; Barata JT
Leukemia; 2013 Jul; 27(7):1603-6. PubMed ID: 23448994
[No Abstract] [Full Text] [Related]
29. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
[TBL] [Abstract][Full Text] [Related]
30. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
31. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
Janssen JW; Ludwig WD; Sterry W; Bartram CR
Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
[TBL] [Abstract][Full Text] [Related]
32. NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.
Chang PY; Draheim K; Kelliher MA; Miyamoto S
Cancer Res; 2006 Jun; 66(12):6008-13. PubMed ID: 16778171
[TBL] [Abstract][Full Text] [Related]
33. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
34. MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.
Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
Technol Cancer Res Treat; 2020; 19():1533033820934130. PubMed ID: 32633635
[TBL] [Abstract][Full Text] [Related]
35. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
Laukkanen S; Oksa L; Nikkilä A; Lahnalampi M; Parikka M; Seki M; Takita J; Degerman S; de Bock CE; Heinäniemi M; Lohi O
Leuk Lymphoma; 2020 Dec; 61(13):3089-3100. PubMed ID: 32835548
[TBL] [Abstract][Full Text] [Related]
36. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
37. The enhancer RNA
Tan SH; Leong WZ; Ngoc PCT; Tan TK; Bertulfo FC; Lim MC; An O; Li Z; Yeoh AEJ; Fullwood MJ; Tenen DG; Sanda T
Blood; 2019 Jul; 134(3):239-251. PubMed ID: 31076442
[TBL] [Abstract][Full Text] [Related]
38. Analysis of chromatin-state plasticity identifies cell-type-specific regulators of H3K27me3 patterns.
Pinello L; Xu J; Orkin SH; Yuan GC
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E344-53. PubMed ID: 24395799
[TBL] [Abstract][Full Text] [Related]
39. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
40. Genetic and epigenetic determinants mediate proneness of oncogene breakpoint sites for involvement in TCR translocations.
Larmonie NS; van der Spek A; Bogers AJ; van Dongen JJ; Langerak AW
Genes Immun; 2014 Mar; 15(2):72-81. PubMed ID: 24304972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
